White label – Pompe disease - ClinicalTrials.eu

Study on Bowel Urgency in Adults with Moderate to Severe Ulcerative Colitis Treated with Mirikizumab

Not recruiting

3 1 1
Investigated Diseases:
- Colitis ulcerative
Investigated Drugs:
- Mirikizumab
+3
Study on Volixibat for Treating Itching in Patients with Primary Sclerosing Cholangitis

Not recruiting

2 1 1
Investigated Drugs:
- Volixibat
Study on JNJ-81201887 for Treating Geographic Atrophy in Age-related Macular Degeneration Patients

Not recruiting

2 1 1
Investigated Diseases:
- Dry age-related macular degeneration
Investigated Drugs:
+5
Study on the Safety and Effectiveness of ABBV-668 for Adults with Moderate to Severe Ulcerative Colitis

Not recruiting

2 1 1
Investigated Diseases:
- Colitis ulcerative
Investigated Drugs:
- Abbv-668
Study of BMS-986442 and Nivolumab, Alone or with Chemotherapy, for Patients with Advanced Solid Tumors and Non-Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm
- Non-small cell lung cancer
Investigated Drugs:
Study on the Effectiveness and Safety of Bemnifosbuvir for High-Risk COVID-19 Patients

Not recruiting

3 1 1
Investigated Diseases:
- COVID-19
Investigated Drugs:
- Bemnifosbuvir Hemisulfate
- Nirmatrelvir
Study of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema

Not recruiting

3 1
Investigated Diseases:
- Dermatitis atopic
Investigated Drugs:
- Upadacitinib
+3
Study of Magrolimab and Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Stem Cell Transplantation

Not recruiting

2 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
Study on the Effectiveness of Co-Trimoxazole for Treating Ventilator-Associated Pneumonia in ICU Patients Compared to a Drug Combination

Not recruiting

3 1 1 1
Investigated Diseases:
- Pneumonia
Investigated Drugs:
Study of Obexelimab for Patients with Warm Autoimmune Hemolytic Anemia

Not recruiting

3 1
Investigated Diseases:
- Warm autoimmune haemolytic anaemia
Investigated Drugs:
- Obexelimab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies